Peripheral Nerve Regeneration

Gene Modulation Identified During Spinal Cord Injury

Published in Gene Therapy Weekly, April 13th, 2000

The Immune Response Corp. (IMNR), Carlsbad, California, announced that it has made progress in identifying the gene expression patterns following anti-inflammatory treatment for spinal cord injury and the genetic basis underlying peripheral nerve regeneration.

The results from microarray (gene chip) studies reported at the American Society for Experimental Neurotherapeutics, held in Washington, DC, during March 2000, might provide the basis for developing new treatments for acute and chronic spinal cord injury.

"Methylprednisolone, an anti-inflammatory steroid, has been the standard of care for patients with acute spinal cord injury. We are now...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Gene Therapy Weekly

Source: Gene Therapy Weekly (2000-04-13)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry